Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Dev Psychol ; 52(12): 2145-2158, 2016 12.
Article in English | MEDLINE | ID: mdl-27893250

ABSTRACT

Public prekindergarten (pre-K) programs have been a recent focus of policy and research attention, in part because of their empirically documented, positive short-term impacts on child cognitive development and school readiness. However, no studies have explored factors that might explain variation across schools in public pre-K impacts. The current study examines the Tulsa Public School pre-K program's impacts on children's letter-word identification, spelling, and applied problem-solving skills at kindergarten entry. Findings reveal substantial across-school variation in treatment impacts, associated with variation in instructional support. Results are robust to sensitivity checks and are discussed alongside implications for policy and future research. (PsycINFO Database Record


Subject(s)
Child Development/physiology , Cognition/physiology , Conditioning, Operant/physiology , Early Intervention, Educational , Language , Attention/physiology , Child, Preschool , Female , Humans , Male , Neuropsychological Tests , Residence Characteristics , Retrospective Studies , Verbal Learning
2.
Cereb Cortex ; 23(6): 1396-409, 2013 Jun.
Article in English | MEDLINE | ID: mdl-22615141

ABSTRACT

Two experiments are reported in which rats with selective hippocampal lesions were tested on 2 prefrontal-dependent tasks. In Experiment 1, we compared the effects of lesions of the ventral hippocampus (vHC), dorsal hippocampus (dHC), and sham control surgery on the 5-choice reaction time task. Whereas rats with lesions of the dHC were indistinguishable from sham controls, those with vHC lesions showed increased premature responses and reduced accuracy throughout the experiment. The subsequent administration of systemic escitalopram (5 mg/kg), a selective serotonin reuptake inhibitor, reduced the number of premature responses in the vHC animals to control levels. In contrast, systemic injections of GBR 12909, a dopamine reuptake inhibitor, failed to ameliorate the impulsive deficit in the vHC group and, in addition, elevated perseverative responding in the vHC group only. In Experiment 2, we tested a separate group of rats with vHC lesions on a touchscreen visual discrimination and reversal learning task. Rats with vHC lesions acquired the visual discrimination as well as sham controls and showed normal inhibitory control of a previously reinforced response during reversal learning. These data support a role for the vHC in inhibitory control functions, especially in the inhibitory control of impulsive actions.


Subject(s)
Choice Behavior/physiology , Discrimination, Psychological/physiology , Hippocampus/injuries , Impulsive Behavior/physiopathology , Inhibition, Psychological , Analysis of Variance , Animals , Attention/drug effects , Attention/physiology , Choice Behavior/drug effects , Citalopram/pharmacology , Discrimination, Psychological/drug effects , Dopamine Uptake Inhibitors/pharmacology , Dose-Response Relationship, Drug , Food Preferences/drug effects , Food Preferences/physiology , Hippocampus/physiology , Impulsive Behavior/chemically induced , Male , Photic Stimulation , Piperazines/pharmacology , Rats , Rats, Long-Evans , Reaction Time/drug effects , Reaction Time/physiology , Reversal Learning/drug effects , Selective Serotonin Reuptake Inhibitors/pharmacology , Sucrose/administration & dosage , Sweetening Agents/administration & dosage
3.
Health Serv Res ; 43(3): 951-70, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18454775

ABSTRACT

OBJECTIVE: To examine state policies associated with adoption of a pharmaceutical agent-naltrexone-by substance abuse treatment facilities to treat alcohol-dependent clients. DATA SOURCES: Facility-level data from the 2003 National Survey of Substance Abuse Treatment Services, and state-level data on policy and environmental factors from publicly available sources. STUDY DESIGN: We use facility- and state-level data in a cross-sectional, multilevel model to analyze state-level policies that are associated with treatment facilities' naltrexone adoption. DATA COLLECTION/EXTRACTION METHODS: The analysis uses survey data. PRINCIPAL FINDINGS: State Medicaid policies supporting the use of generic drugs, reducing drug costs, and permitting managed care organizations to establish policies encouraging use of generics were associated with higher odds of naltrexone adoption (by up to 96 percent). State policies limiting access to pharmaceutical technologies through Medicaid preferred drug lists, restricting access to pharmacy networks, and imposing general limitations on use of Medicaid benefits for rehabilitation for substance abuse treatment were associated with reduced odds of naltrexone adoption. CONCLUSIONS: Policy levers that are available to state governments are associated with the adoption of pharmaceutical technologies such as naltrexone that could help meet widespread need for access to clinically proven and cost-effective treatments for substance abuse.


Subject(s)
Alcoholism/drug therapy , Diffusion of Innovation , Naltrexone/therapeutic use , Narcotic Antagonists/therapeutic use , Policy Making , State Government , Adult , Cost Control , Cross-Sectional Studies , Drug Costs , Drugs, Generic , Humans , Naltrexone/economics , Narcotic Antagonists/economics , United States
SELECTION OF CITATIONS
SEARCH DETAIL
...